Literature DB >> 12843107

Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.

Yajarayma Tang-Feldman1, Susan Mayo, Joseph Silva, Stuart H Cohen.   

Abstract

Recurrence of Clostridium difficile-associated diarrhea (CDAD) occurs in 15 to 20% of patients after discontinuation of treatment. Arbitrarily primed PCR was used to investigate the epidemiology of recurrent CDAD in 18 patients. Reinfection with a new strain occurred in 6 of 18 patients (33.3%), while 12 patients relapsed with the original strain shortly after discontinuation of treatment. These data suggest that reinfection with exogenous C. difficile is a common problem and that not all recurrences are due to relapse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843107      PMCID: PMC165369          DOI: 10.1128/JCM.41.7.3413-3414.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Molecular typing methods for the epidemiological identification of Clostridium difficile strains.

Authors:  S H Cohen; Y J Tang; J Silva
Journal:  Expert Rev Mol Diagn       Date:  2001-05       Impact factor: 5.225

2.  Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

Authors:  S Johnson; A Adelmann; C R Clabots; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

Review 3.  Typing of Clostridium difficile.

Authors:  J S Brazier
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

4.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

5.  Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea.

Authors:  R Alonso; S Gros; T Peláez; D García-de-Viedma; M Rodríguez-Créixems; E Bouza
Journal:  J Hosp Infect       Date:  2001-06       Impact factor: 3.926

6.  Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.

Authors:  R Fekety; L V McFarland; C M Surawicz; R N Greenberg; G W Elmer; M E Mulligan
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

Review 7.  Clostridium difficile infection: responses, relapses and re-infections.

Authors:  M H Wilcox; R C Spencer
Journal:  J Hosp Infect       Date:  1992-10       Impact factor: 3.926

8.  Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates.

Authors:  Y J Tang; S T Houston; P H Gumerlock; M E Mulligan; D N Gerding; S Johnson; F R Fekety; J Silva
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

10.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

View more
  16 in total

1.  Relapse versus reinfection: surveillance of Clostridium difficile infection.

Authors:  Mini Kamboj; Perminder Khosa; Anna Kaltsas; N Esther Babady; Crystal Son; Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

Review 2.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases.

Authors:  Kentaro Oka; Takako Osaki; Tomoko Hanawa; Satoshi Kurata; Mitsuhiro Okazaki; Taki Manzoku; Motomichi Takahashi; Mamoru Tanaka; Haruhiko Taguchi; Takashi Watanabe; Takashi Inamatsu; Shigeru Kamiya
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  Treatment of Recurrent Clostridium difficile Diarrhea.

Authors:  Elizabeth S Huebner; Christina M Surawicz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

Review 6.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

Review 7.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

Review 8.  Treating Clostridium difficile infection with fecal microbiota transplantation.

Authors:  Johan S Bakken; Thomas Borody; Lawrence J Brandt; Joel V Brill; Daniel C Demarco; Marc Alaric Franzos; Colleen Kelly; Alexander Khoruts; Thomas Louie; Lawrence P Martinelli; Thomas A Moore; George Russell; Christina Surawicz
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

Review 9.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

10.  Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology.

Authors:  Seth T Walk; Vincent B Young
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.